Fresenius | FRE - Cost Of Sales

Stock Price
50.96
Daily Change
-0.36 -0.70%
Monthly
6.95%
Yearly
32.50%
Q1 Forecast
50.68

Fresenius reported EUR4.45B in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Akzo Nobel EUR 1.44B 84M Dec/2025
Alcon AG USD 1.16B 52M Sep/2025
AstraZeneca USD 3.27B 471M Dec/2025
BASF EUR 11.17B 424M Sep/2025
Bayer EUR 4.31B 57M Sep/2025
Beiersdorf EUR 2.11B 130M Jun/2025
DaVita Healthcare Partners USD 2.6B 263.46M Dec/2025
Demant DKK 2.89B 188M Dec/2025
E.ON EUR 11.33B 285M Sep/2025
Essilor EUR 6.06B 741M Dec/2025
Fresenius EUR 4.45B 262M Dec/2025
Fresenius Medical Care EUR 3.68B 38.37M Dec/2025
Getinge SEK 6.02B 1.7B Dec/2024
Givaudan CHF 1.05B 936.5M Jun/2024
GlaxoSmithKline GBP 2.61B 377M Dec/2025
GN Store Nord DKK 2.24B 338M Dec/2025
GRIFOLS EUR 1.13B 15.63M Sep/2025
Hikma Pharmaceutical USD 466.5M 428.5M Jun/2025
Lonza CHF 2.28B 189M Jun/2025
Merck EUR 2.1B 123M Sep/2025
Novartis USD 3.54B 217M Sep/2025
Philips EUR 2.81B 417M Dec/2025
Roche Holding CHF 8.48B 4.61B Dec/2025
RWE EUR 2.48B 938M Sep/2025
Sanofi EUR 4.29B 421M Dec/2025
Smith & Nephew USD 870M 17M Dec/2025